Chang, M.R., Lyda, B., Kamenecka, T.M, & Griffin, P. R. (2014). Pharmacologic repression of retinoic acid receptor-related orphan nuclear receptor γ is therapeutic in the collagen-induced arthritis experimental model. Arthritis Rheumatol, 66(3), 579-588. doi: 10.1002/art.38272
Fontenot, J.D., Rasmussen, J.P., Gavin, M.A., & Rudensky, A.Y. (2005). A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol, 6(11), 1142-1151. doi: 10.1038/ni1263
Fox, RI., & Stern, M. (2002). Sjögren’s syndrome: mechanisms of pathogenesis involve interaction of immune and neurosecretory systems. Scand J Rheumatol Suppl, 116, 3-13 Gueiros, L.A., France, K., Posey, R., Mays, J.W, Carey, B., Sollecito, T.P, …De Rossi, S. (2019). World Workshop on Oral Medicine VII: Immunobiologics for salivary gland disease in Sjögren's syndrome: A systematic review. Oral Dis, 25 (Suppl 1), 102-110. doi: 10.1111/odi.13062
Guo, Y., Maclsaac, K.D, Chen, Y., Miller, R.J., Jain, R., Joyce-Shaikh, B., …Cua, D.J. (2016). Inhibition of RORγT Skews TCRa Gene Rearrangement and Limits T cell Repertoire Diversity. Cell Rep, 17(12), 3206-3218. Doi: 10.1016/j.celrep.
Iizuka, M., Tsuboi, H., Asashima, H., Hirota, T., Kondo, Y., Matsui, M., …Sumida, T. (2015). M3 muscarinic acetylcholine receptor reactive IL-17 producing T cells promotes development of Sjögren's syndrome like sialadenitis. Mod Rheumatol, 25(1), 158-160. doi: 10.3109/14397595.2014.884683
Iizuka, M., Tsuboi, H., Matsuo, N., Asashima, H., Hirota, T., Kondo, Y., …Sumida T. (2015). A crucial role of RORγt in the development of spontaneous sialadenitis-like Sjögren’s syndrome. J Immunol, 194, 56-67. doi: 10.4049/jimmunol.1401118
Iizuka, M., Tsuboi, H., Matsuo, N., Kondo, Y., Asashima, H., Matsui, M., …Sumida, T. (2013). The crucial roles of IFN-γ in the development of M3 muscarinic acetylcholine receptor induced Sjögren's syndrome-like sialadenitis. Mod Rheumatol, 23(3), 614-616. doi: 10.1007/s10165-012-0785-8
Iizuka, M., Wakamatsu, E., Tsuboi, H., Nakamura, Y., Hayashi, T., Matsui, M., …Sumida, T. (2010). Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjögren’s syndrome-like sialadenitis. J Autoimmun, 35(4), 383-389. doi: 10.1016/j.jaut.2010.08.004
Ivanov, I.I., McKenzie, B.S., Zhou, L., Tadokoro, C.E, Lepelley, A., Lafaille, J.J, … Littman, D.R. (2006). The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell, 26, 1121-1133. doi: 10.1016/j.cell.2006.07.035
Ivanov, I.I., Zhou, L., & Littman, D.R. (2007). Transcriptional regulation of Th17 cell differentiation. Semin Immunol, 19, 409-417. doi: 10.1016/j.smim.2007.10.011
Katsifis, G.E., Rekka, S., Moutsopoulos, N.M, Pillemer, S., & Wahl, S. M. (2009). Systemic and local interleukin-17 and linked cytokines associated with Sjögren’s syndrome immunopathogenesis. Am J Pathol, 175(3), 1167-1177. doi: 10.2353/ajpath.2009.090319 Liu, J., Bai, L.P., Yang, F., Lei, K., Kei-Lam, C.W., Wu, Q., …Liu, L. (2019). Potent Antagonists of RORγt, Cardenolides from Calotropis gigantea, Exhibit Discrepant Effects on the Differentiation of T Lymphocyte Subsets. Mol Pharm, 16(2):798-807. doi: 10.1021/acs.molpharmaceut.8b01063
Manel, N., Unutmaz, D., & Littman, D.R. (2008). The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt. Nat. Immunol, 9, 641–649.
McGeehan, G.M., Palmer, S.A., Bryson, C.C., Zhao, Y., Shi, M., Lipinski, K.K, …Gregg, R.E. (2016). Safety, tolerability, pharmacokinetics and pharmacodynamics of VTP-43742, a RORγt inhibitor, in normal healthy volunteers. J Immunol, 196, (1 Suppl.), 71.4 Nandula, S.R., Scindia, Y. M., Dey, P., Bagavant, H., & Deshmukh, U.S. (2011). Activation of innate immunity accelerates sialoadenitis in a mouse model for Sjögren's syndrome-like disease. Oral Dis, 17(8), 801-807. doi: 10.1111/j.1601-0825.2011.01839
Nguyen, C.Q., Hu, M.H., Li, Y., Stewart, C., & Peck, A. B. (2008). Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren’s syndrome: findings in humans and mice. Arthritis Rheum, 58(3), 734-743. doi: 10.1002/art.23214
Sakai, A., Sugawara, Y., Kuroishi, T., Sasano, T., & Sugawara, S. (2008). Identification of IL-18 and Th17 cells in salivary glands of patients with Sjögren’s syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. J Immunol, 181(4), 2898-2906.
Sancho, D., Gómez, M., & Sánchez-Madrid, F. (2005). CD69 is an immunoregulatory molecule induced following activation. Trends Immunol, 26(3), 136-140. doi: 10.1016/j.it.2004.12.006
Solt, L.A., Banerjee, S., Campbell, S., Kamenecka, T. M., & Burris, T. P. (2015). ROR inverse agonist suppresses insulitis and prevents hyperglycemia in a mouse model of type 1 diabetes. Endocrinology, 156, 869-881. doi: 10.1210/en.2014-1677
Tahara, M., Tsuboi, H., Segawa, S., Asashima, H, Iizuka-koga, M., Hirota, T., …Sumida, T. (2017). RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjögren’s syndrome-like sialadenitis. Clin Exp Immunol, 187(2), 213-224. doi: 10.1111/cei.12868
Takaishi, M., Ishizaki, M., Suzuki, K., Isobe, T., Shimozato, T., & Sano, S. (2017). Oral administration of a novel RORγt antagonist attenuates psoriasis-like skin lesion of two independent mouse models through neutralization of IL-17. J Dermatol Sci, 85, 12-19. doi: 10.1016/j.jdermsci.2016.10.001
Theze, J., Alzari, P. M., & Bertoglio, J. (1996). Interleukin 2 and its receptors: recent advances and new immunological functions. Immunol Today, 17(10):481-486
Yang, X.O., Pappu, B.P., Nurieva, R., Akimzhanov, A., Kang, H.S., Chung, Y., … Dong, C. (2008). T helper 17 lineage differentiation is programmed by orphan nuclear receptors RORα and RORγ. Immunity, 28(1), 29-39. doi: 10.1016/j.immuni.2007.11.016
論文の公開元へ
